Probiotics in Case of Antibiotic-Associated Diarrhea in Children: an Informed Choice

Main Article Content

O.Ju. Belousova


Administration of probiotic strains for the prevention of antibiotic-associated diarrhea (AAD) in adults and children at the moment is the standard regimen of both Ukrainian and European treatment protocols. Saccharomyces boulardii are yeast probiotics. Their basic difference from bacterial probiotics (Lactobacіllus, etc.) is a resistance to antibiotics. In this regard, Saccharomyces boulardii can be used in conjunction with antibiotics for the prevention of side effects from the digestive tract caused by antibiotic therapy (especially AAD). The choice in this situation of a bacterial probiotic is less successful, because antibiotics can inhibit the activity of introduced bacteria. Importantly, Saccharomyces boulardii are not able to transfer antibiotic resistance to pathogenic bacteria, while bacterial probiotics have such a potential. The results of the clinical studies show high efficacy and safety of Saccharomyces boulardii in the prevention and treatment of antibiotic-associated diarrhea in children. In Ukraine, this probiotic is presented by Enterol®.

Article Details

How to Cite
Belousova, O. “Probiotics in Case of Antibiotic-Associated Diarrhea in Children: An Informed Choice”. CHILD`S HEALTH, no., Oct. 2016, pp. 15-22, doi:10.22141/2224-0551.
Review of Literature


[Pediatricians of Ukraine - for rational antimicrobial therapy]. Zdorov'ya Ukrayiny`. 2010 Apr;19-20. Russian

Zaharenko SM. [Modern approaches to the prevention of antibiotic-associated suppression of the microflora of the gastrointestinal tract]. Lechashhij vrach. 2010;(11):68–73. Russian

[Innovative approaches to correction of microbiome in pediatric practice]. Zdorov'ya Ukrayiny`. 2016 Jun;4–6. Russian

[Rehabilitation of children with chronic diseases: problems and perspectives]. Ukr. med. chasopy`s. 2015;(110):32–35. Russian

Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, Vorisek V, Kopacova, M. [Small intestinal bacterial overgrowth syndrome]. World Journal of Gastroenterology. 2010;16(24):2978–2990. English

Belousova OJu. [Differentiated approach to the administration of probiotics for the correction of gastrointestinal disorders in infants] Association of Pediatric Gastroenterologists and Nutritionists of Ukraine. 2015. Russian

Chernikov VV, Surkov AN. [Antibiotic-associated diarrhea in children: the principles of prevention and treatment]. Voprosy sovremennoj pediatrii. 2012;11(2):48–55. Russian

Shul'pekova JuO. [Diarrhea associated with antibiotics intake, and probiotics for its prevention and treatment]. Russkij medicinskij zhurnal. 2010;(2):82-85. Russian

Zakordonec LV, Kramarev SA, Beregovaja TV, Tolstanova AN, Dovbinchuk TV. [Antibiotic-associated diarrhea: mechanisms of development and the possibility of correction]. Zdorov'e rebenka. 2013;(7):69–73. Russian

Surkov AN. [Modern technologies of treatment and prophylaxis of antibiotic-associated diarrhea in children]. Voprosy sovremennoj pediatrii. 2011;10(5):146–151. Russian

Antibiotic resistance in pediatric practice: the problem and its solution // Zdorov'ya Ukrayiny`. 2016 Jun;15–16. Russian

Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH. [Probiotics for the prevention of pediatric antibiotic-associated diarrhea]. Cochrane Database Syst Rev. 2011 Nov 9;(11):CD004827. English

Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, Thomson A, Krabshuis J, Lemair T, Kaufmann P, de Paula JA, Fedorak R, Shanahan F, Sanders ME, Szajewska H, Ramakrishna BS, Karakan T, Kim N; World Gastroenterology Organization. [World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011]. J Clin Gastroenterol. 2012 Jul;46(6):468-81. English

Videlock EJ. [Meta-analysis: probiotics in antibiotic-associated diarrhea] Aliment Pharmacol Ther. 2012 Jun;35(12):1355-69. English

Pattani R, Palda VA, Hwang SW, Shah PS. [Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis]. Open Med. 2013 May 28;7(2):e56-67. English

Micklefield G. [Saccharomyces boulardii in the treatment and prevention of antibiotic-associated diarrhea]. MMW Fortschr Med. 2014 Apr 17;156 Suppl 1:18-22. German

McFarland LV. [Systematic review and meta-analysis of Saccharomyces boulardii in adult patients]. World J Gastroenterol. 2010 May 14;16(18):2202-22. English

Shan LS, Hou P, Wang ZJ, Liu FR, Chen N, Shu LH, Zhang H, Han XH, Han XX, Cai XX, Shang YX, Vandenplas Y. [Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections]. Benef Microbes. 2013 Dec 1;4(4):329-34. English

Floch MH, Walker WA, Sanders ME, Nieuwdorp M, Kim AS, Brenner DA, Qamar AA, Miloh TA, Guarino A, Guslandi M, Dieleman LA, Ringel Y, Quigley EM, Brandt LJ. [Recommendations for Probiotic Use--2015 Update: Proceedings and Consensus Opinion]. J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S69-73. English

Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ; European Helicobacter Study Group. [Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report]. Gut. 2012 May;61(5):646-64. English

Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, Vandenplas Y, Weizman Z; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. [Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics]. J Pediatr Gastroenterol Nutr. 2014 Apr;58(4):531-9. English